ClearPoint Neuro, Inc. 8-K

What Happened
ClearPoint Neuro, Inc. (CLPT) filed a Form 8‑K on May 13, 2026 to announce its financial results for the first fiscal quarter ended March 31, 2026. The company furnished a press release with those results as Exhibit 99.1 and also posted an updated investor presentation to its investor website, furnished as Exhibit 99.2. The filing is signed by CFO Danilo D’Alessandro.

Key Details

• Filing date: May 13, 2026 (Form 8‑K).
• Quarter covered: Q1 ended March 31, 2026.
• Materials furnished: Exhibit 99.1 — press release announcing Q1 financial results; Exhibit 99.2 — updated investor presentation (posted at http://ir.stockpr.com/clearpointneuro/investor-presentations).
• Signed by: Danilo D’Alessandro, Chief Financial Officer (dated May 13, 2026).

Why It Matters
This 8‑K provides the company’s official quarterly results and refreshed investor materials, which are primary sources for assessing ClearPoint’s recent operational and financial performance. The updated investor presentation may include management commentary, metrics, or guidance that investors and analysts will use alongside the press release to evaluate near‑term prospects. The Regulation FD disclosure and furnishing of exhibits ensure the information was broadly distributed and documented for investors.